Translumina Therapeutics, India’s largest domestic player in the coronary stents market, announces the initiation of direct operations in the UAE

Translumina, a global leader in Interventional Cardiovascular medical devices with manufacturing presence in Germany and India, today announced the acquisition of Blue Medical Devices, a Wellinq group company, based out of Helmond, Netherlands.

Translumina further strengthens Its technology portfolio with acquisition of Blue Medical Devices, Netherlands

The acquisition gives access to a patented, innovative, and proven next-generation Drug Coated Balloon (DCB) technology that may revolutionize the scope of complex coronary interventions